[HTML][HTML] Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic

AIS van den Berg, CO Yun, RM Schiffelers… - Journal of Controlled …, 2021 - Elsevier
Gene therapy using nucleic acids has many clinical applications for the treatment of
diseases with a genetic origin as well as for the development of innovative vaccine …

MicroRNAs as biomarker for breast cancer

T Aggarwal, R Wadhwa, R Gupta… - … Metabolic & Immune …, 2020 - ingentaconnect.com
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million
women all over the world. Since the last decade, genome-wide association studies (GWAS) …

Molecular mechanisms of p53 deregulation in cancer: an overview in multiple myeloma

AB Herrero, EA Rojas, I Misiewicz-Krzeminska… - International journal of …, 2016 - mdpi.com
The p53 pathway is inactivated in the majority of human cancers. Although this perturbation
frequently occurs through the mutation or deletion of p53 itself, there are other mechanisms …

[HTML][HTML] MicroRNA-19 triggers epithelial–mesenchymal transition of lung cancer cells accompanied by growth inhibition

J Li, S Yang, W Yan, J Yang, YJ Qin, XL Lin… - Laboratory …, 2015 - Elsevier
Abstract The miR-19 family (miR-19a and miR-19b-1) are key oncogenic components of the
miR-17-92 cluster. Overexpression of miR-19 is strongly associated with cancer invasion …

Regulation of mutant p53 protein expression

R Vijayakumaran, KH Tan, PJ Miranda, S Haupt… - Frontiers in …, 2015 - frontiersin.org
For several decades, p53 has been detected in cancer biopsies by virtue of its high protein
expression level which is considered indicative of mutation. Surprisingly, however, mouse …

Are microRNAs true sensors of ageing and cellular senescence?

J Williams, F Smith, S Kumar, M Vijayan… - Ageing research reviews, 2017 - Elsevier
All living beings are programmed to death due to aging and age-related processes. Aging is
a normal process of every living species. While all cells are inevitably progressing towards …

[HTML][HTML] Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics …

P Singh, R Solanki, A Tasneem, S Suri, H Kaur… - Journal of Genetic …, 2024 - Elsevier
Background The hepatocellular carcinoma (HCC) incident rate is gradually increasing
yearly despite all the research and efforts taken by scientific communities and governing …

MicroRNAs, aging, cellular senescence, and Alzheimer's disease

PH Reddy, J Williams, F Smith, JS Bhatti… - Progress in molecular …, 2017 - Elsevier
Aging is a normal process of living being. It has been reported that multiple cellular changes,
including oxidative damage/mitochondrial dysfunction, telomere shortening, inflammation …

Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis

H Zhang, Y Wang, J Dou, Y Guo, J He, L Li, X Liu… - Oncogene, 2019 - nature.com
Abstract Argonaute2 (AGO2) is an effector of small RNA mediated gene silencing.
Increasing evidence show that post-translational modifications of AGO2 can change miRNA …

Angiogenic role of miR-20a in breast cancer

G Luengo-Gil, E Gonzalez-Billalabeitia… - PloS one, 2018 - journals.plos.org
Background Angiogenesis is a key process for tumor progression and a target for treatment.
However, the regulation of breast cancer angiogenesis and its relevance for clinical …